Overview
-


₹11.00
▼ 0.05
(0.45%)
Funds in the same category by AUM
You can invest in Baroda BNP Paribas Health and Wellness Fund-Dir(G) through a lump sum investment or a monthly SIP. The minimum lump sum investment is ₹1,000 and the minimum SIP amount is ₹500.
The latest NAV of Baroda BNP Paribas Health and Wellness Fund-Dir(G) is ₹11.00.
Baroda BNP Paribas Health and Wellness Fund-Dir(G) manages assets worth ₹507.42 Cr.
The expense ratio of Baroda BNP Paribas Health and Wellness Fund-Dir(G) is 1.56%.
The exit load applicable on Baroda BNP Paribas Health and Wellness Fund-Dir(G) is Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment Exit load NIL. For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment 1.00% of applicable NAV. For redemption/switch out of units after 1 year from the date of allotment Nil..
As per the riskometer, Baroda BNP Paribas Health and Wellness Fund-Dir(G) carries Very High risk.
Baroda BNP Paribas Health and Wellness Fund-Dir(G) is managed by Baroda BNP Paribas Mutual Fund.
Baroda BNP Paribas Health and Wellness Fund-Dir(G) belongs to the Sectoral Fund category.
Baroda BNP Paribas Health and Wellness Fund-Dir(G) is benchmarked against the BSE Healthcare TRI.
Baroda BNP Paribas Health and Wellness Fund-Dir(G) has no lock-in period, so units can be redeemed at any time subject to the applicable exit load.
Baroda BNP Paribas Health and Wellness Fund-Dir(G) was launched on 27 Jun 2025.
After the initial investment, you can invest in Baroda BNP Paribas Health and Wellness Fund-Dir(G) in further multiples of ₹1,000.
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
27 Jun 2025
₹507.42 Cr
₹11.00
₹500
₹1,000
Very High
1.56%
8.69
0.48
0.33
3.82
0.52
0.09
0.71
Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment Exit load NIL. For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment 1.00% of applicable NAV. For redemption/switch out of units after 1 year from the date of allotment Nil.
This fund has Very High risk.
Returns over a year are annualised (per year, compounded).
Funds in the same category by AUM